JAHA:心血管疾病治疗的新方法“冥想”

2017-09-29 白木清水 来宝网

冥想有可能减少心脏病的一些危险因素,但根据美国心脏协会新的科学声明,降低风险的黄金标准仍然是心脏健康的生活方式和医疗建议。

冥想有可能减少心脏病的一些危险因素,但根据美国心脏协会新的科学声明,降低风险的黄金标准仍然是心脏健康的生活方式和医疗建议

研究表明,冥想可以对大脑产生长期影响,如何运作,并且已经出版了关于冥想潜在益处的许多研究,这促使美国心脏协会审查当前的高质量科学研究,以确定是否实践中有减轻心脏病的作用。

虽然冥想的做法可追溯到公元前5000年,与某些哲学和宗教有关,冥想越来越多地被实践为一种世俗和治疗活动。约有8%的美国人采取某种冥想,而在国家健康访谈调查中,由国家卫生研究院组成的国家健康和综合卫生中心进行,17%的心血管疾病患者表达了兴趣参加冥想临床试验。

由心血管疾病专家和神经科学家组成的写作小组审查了现有的关于常规冥想类型是否对心血管危险因素和疾病有影响的研究。

该评论排除了对瑜伽和太极拳组合心理实践的研究,因为这些实践中包括的体力活动对心脏病风险具有确定的积极影响。坐着冥想的研究,包括各种常见的形式,如:Samatha; Vipassana(洞察冥想);思想冥想;拉贾瑜伽慈爱(Metta);超验冥想和放松表明冥想:

可能与压力,焦虑和抑郁水平降低,睡眠质量和总体福祉有关;

可能有助于降低血压,虽然没有足够的证据来确定某一个体是否或多少可能降低血压;

可以帮助个人戒烟

可能与心脏病发作风险降低有关,虽然只有少数研究,但在作出任何结论之前需要更多的研究。

AHA科学声明撰写组主席Glenn N. Levine博士说:“虽然冥想研究表明心血管风险可能有益,但尚未有足够的研究结论,它具有明确的作用。”在美国心脏协会杂志,美国心脏协会/美国中风协会的开放获取期刊。

“由于教育如何冥想是广泛可用的,冥想几乎没有与之相关的风险,感兴趣的人可能希望使用这些技术,除了既定的医疗和生活方式的干预措施,作为降低心脏病风险的一种可能的方式。在德克萨斯州休斯敦贝勒医学院医学教授Levine说,重要的是人们明白好处仍然更好,冥想不能代替传统医疗。

Levine指出,直到我们知道更多,预防和治疗心脏病的支柱仍然是经过仔细研究和展示的生活方式咨询和治疗,包括胆固醇治疗,血压控制,戒烟和定期的身体活动。

原始出处:

Glenn N. Levine, Richard A. Lange, C. Noel Bairey‐Merz, et al. Meditation and Cardiovascular Risk Reduction. Journal of the American Heart Association. 2017;6:e002218. Originally published September 28, 2017.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1982777, encodeId=22ff1982e7757, content=<a href='/topic/show?id=89c4e06902e' target=_blank style='color:#2F92EE;'>#疾病治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70690, encryptionId=89c4e06902e, topicName=疾病治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Mon Aug 27 06:33:00 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903274, encodeId=09fc19032e484, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Tue Oct 24 12:33:00 CST 2017, time=2017-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267555, encodeId=d636126e55531, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Sep 30 23:33:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498290, encodeId=b1d114982909b, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Sat Sep 30 23:33:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248741, encodeId=aa38248e4143, content=冥想去哈哈, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/27/c3e43bd6e32a923e5039c647133f8782.jpg, createdBy=b0b92146849, createdName=小鹿啊, createdTime=Fri Sep 29 08:42:45 CST 2017, time=2017-09-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1982777, encodeId=22ff1982e7757, content=<a href='/topic/show?id=89c4e06902e' target=_blank style='color:#2F92EE;'>#疾病治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70690, encryptionId=89c4e06902e, topicName=疾病治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Mon Aug 27 06:33:00 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903274, encodeId=09fc19032e484, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Tue Oct 24 12:33:00 CST 2017, time=2017-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267555, encodeId=d636126e55531, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Sep 30 23:33:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498290, encodeId=b1d114982909b, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Sat Sep 30 23:33:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248741, encodeId=aa38248e4143, content=冥想去哈哈, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/27/c3e43bd6e32a923e5039c647133f8782.jpg, createdBy=b0b92146849, createdName=小鹿啊, createdTime=Fri Sep 29 08:42:45 CST 2017, time=2017-09-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1982777, encodeId=22ff1982e7757, content=<a href='/topic/show?id=89c4e06902e' target=_blank style='color:#2F92EE;'>#疾病治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70690, encryptionId=89c4e06902e, topicName=疾病治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Mon Aug 27 06:33:00 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903274, encodeId=09fc19032e484, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Tue Oct 24 12:33:00 CST 2017, time=2017-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267555, encodeId=d636126e55531, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Sep 30 23:33:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498290, encodeId=b1d114982909b, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Sat Sep 30 23:33:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248741, encodeId=aa38248e4143, content=冥想去哈哈, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/27/c3e43bd6e32a923e5039c647133f8782.jpg, createdBy=b0b92146849, createdName=小鹿啊, createdTime=Fri Sep 29 08:42:45 CST 2017, time=2017-09-29, status=1, ipAttribution=)]
    2017-09-30 zhaohui6731
  4. [GetPortalCommentsPageByObjectIdResponse(id=1982777, encodeId=22ff1982e7757, content=<a href='/topic/show?id=89c4e06902e' target=_blank style='color:#2F92EE;'>#疾病治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70690, encryptionId=89c4e06902e, topicName=疾病治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Mon Aug 27 06:33:00 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903274, encodeId=09fc19032e484, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Tue Oct 24 12:33:00 CST 2017, time=2017-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267555, encodeId=d636126e55531, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Sep 30 23:33:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498290, encodeId=b1d114982909b, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Sat Sep 30 23:33:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248741, encodeId=aa38248e4143, content=冥想去哈哈, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/27/c3e43bd6e32a923e5039c647133f8782.jpg, createdBy=b0b92146849, createdName=小鹿啊, createdTime=Fri Sep 29 08:42:45 CST 2017, time=2017-09-29, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1982777, encodeId=22ff1982e7757, content=<a href='/topic/show?id=89c4e06902e' target=_blank style='color:#2F92EE;'>#疾病治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70690, encryptionId=89c4e06902e, topicName=疾病治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Mon Aug 27 06:33:00 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903274, encodeId=09fc19032e484, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Tue Oct 24 12:33:00 CST 2017, time=2017-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267555, encodeId=d636126e55531, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Sep 30 23:33:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498290, encodeId=b1d114982909b, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Sat Sep 30 23:33:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248741, encodeId=aa38248e4143, content=冥想去哈哈, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/27/c3e43bd6e32a923e5039c647133f8782.jpg, createdBy=b0b92146849, createdName=小鹿啊, createdTime=Fri Sep 29 08:42:45 CST 2017, time=2017-09-29, status=1, ipAttribution=)]
    2017-09-29 小鹿啊

    冥想去哈哈

    0

相关资讯

Radiology:乳房活检时,冥想法有助于女性减轻疼痛

杜克大学癌症研究所的研究人员将研究结果发表在Radiology。人们认为,接受乳房活检十分令人难以接受。怀疑患有乳腺癌需要切除乳房组织的女性需要进行乳房活检,但女性进行乳房活检往往十分疼痛,并且深感焦虑。 Mary Scott Soo博士指出,若在活检过程中病人觉得痛苦和焦虑,则会降低活检的有效性,因此导致患者不会坚持随访检查和评估。 根据美国国立卫生研究院(NIH)既往研究表明,冥想可以降低血压

JAMA Internal Medicine:冥想可缓解老年人腰痛

据发表于 JAMA Internal Medicine的一项新的研究表明,冥想可短期改善慢性腰痛老年患者的功能,改变腰痛的长期趋势,并可缓解患者的疼痛程度。

J Neurosci:冥想也能助你减轻疼痛感!

近日,最新发表在神经科学杂志上的一项研究成果表明,冥想可能比安慰剂能带来更大的疼痛缓解作用。该研究团队的主导者Fadel Zaidan博士和他的同事们在过去就发现期望、分心、专注、信念、安慰剂、催眠、压力、焦虑情绪的影响等都能对疼痛产生重要的作用。而其中认知增强和情绪控制被证实有助于减轻疼痛;亦可称之为冥想作用减轻了疼痛。为了证实该研究成果,Fadel Zaidan博士和他的团队招募了75个志愿者

JAD:瑜伽锻炼能降低老年痴呆的发生

          发表在Journal of Alzheimer's Disease的一项新研究结果显示,完成3个月的瑜伽和冥想练习能够显著降低老年人的轻微认知损伤(简称MCI, mild cognitive impairment)及其他痴呆病的发生。 MCI以认知功能出现可见性的变化为主要特征,表现为

J Neurosci:缓解疼痛,冥想是否可代替阿片类药物?

J Neurosci:缓解疼痛,冥想是否可代替阿片类药物? 据发表于Journal of Neuroscience的一项新的研究显示,冥想可有效减轻疼痛,或是目前疼痛主流的治疗药物阿片类药物的一种替代疗法。

诺奖得主:冥想真能延缓衰老吗?

尽管针对如何解决社会不平等问题的谈论已很常见,但布莱克本说端粒能让我们首次量化压力和不平等对健康造成的影响,从而让我们估算出随之而来的经济损失。我们现在还能将孕期和童年期视为“印记阶段”,在这两个阶段,端粒长度极易受到压力影响。她说这些证据能提供促使政府行动的、更有力的论证。不过大部分科学家和政客似乎仍无意跨越布莱克